The global sports medicine market was valued at approximately $6.1 billion in 2024 and is expected to grow at a rate of ~8% during the forecast period. The growing cases of sports injuries, technological advancements and new product innovations in sports medicine, rising demand for minimally invasive surgeries, development in regenerative medicine, and an increasing awareness of the importance of physical fitness and sports activities are some of the key factors driving the market growth.
Sports medicine is an umbrella term representing a broad array of specialties that bridges the academic disciplines of medicine and physical education as well as the basic sciences. It also entails the treatment of damage to bone, cartilage, and tissue through minimally invasive procedures. The procedures, often in the knee, hip, and shoulder, allow patients to quickly return to their active lifestyles.
Download a free sample report now 👉
https://meditechinsights.com/sports-medicine-market/request-sample/
Potential of sports medicines to treat sports injuries boosts market growth
Sporting injuries are inevitable for anyone who actively engages in physical activity. People of all ages are more active than ever before and whenever they seek treatment for an injury or a degenerative condition, they expect a fast recovery and rapid return to activity. Development in regenerative medicine in the sporting arena focuses predominantly on cartilage, tendon, ligament, meniscal, and skeletal muscle injuries. One such development in regenerative medicine, which is gaining traction for its minimally invasive approach and regenerative potential, is incorporating stem cell-based treatments in sports medicine, specifically mesenchymal stem cells (MSCs), which are currently under clinical trials for their ability to expedite healing in tendon and cartilage injuries.
For instance, in January 2024, Smith+Nephew announced that it had completed the acquisition of CartiHeal, developer of Agili-C, a novel sports medicine technology for cartilage regeneration in the knee.
Technological advancements in the orthopedic field such as the 3D printing of implants and the introduction of bionic technology, and sensor technology in prosthetic limbs offer unprecedented growth opportunities. The future shows a trend toward prevention through genetics, nutrigenomics, and numerous monitors and wearables in sports medicine, which is further expected to drive the market during the forecast period.
Increasing emphasis on developing new advanced sports medicine products
The field of sports medicine encompasses a wide variety of disciplines, from orthopedics and physiotherapy to psychiatry and public health. There have been many recent advances in the products category of sports medicine, such as rotator cuff repair, anterior cruciate ligament reconstruction, high altitude simulation training, anti-gravity treadmill, exoskeletons, bio-harnesses, smart fabrics, virtual and augmented reality and hip/knee arthroscopy that are revolutionizing the global sports medicine market. For instance,
• In January 2023, Arthrex, announced its ACL TightRope implant has received FDA approval for pediatric indications. The anterior cruciate ligament (ACL) injuries are common among young athletes and the TightRope implant is used for the surgical treatment these injuries
• In November 2022, Smith+Nephew announced the introduction of its JOURNEY II ROX Total Knee Solution – a reverse hybrid construct for total knee arthroplasty. This new procedural product solution aims to provide surgeons with the clinical advantage of advanced bearing material and anatomic design combined with the efficiency and potential long-term tibia fixation of a cementless knee
• In March 2022, DePuy Synthes, the Orthopaedics Company of Johnson & Johnson, announced the addition of two innovations to its kinematically advanced and proven ATTUNE Knee portfolio: the ATTUNE Cementless Fixed Bearing Knee with AFFIXIUM 3DP Technology and the ATTUNE Medial Stabilized Knee System.
Rising incidence of youth sports injuries fuels the global sports medicine market
More than 3.5 million children under the age 14 receive medical treatment for sports injuries each year. Young athletes, especially those younger than 8 are more prone to sports injuries than adults due to ongoing growth spurts, slower reaction times, and still-developing hand-eye coordination. Injuries to the face or head are more common and account for 27% of high school sports injuries. Also, more than 775,000 children, ages 14 and younger, are treated in hospital emergency rooms for sports-related injuries each year.
Competitive Landscape Analysis
The global sports medicine market is marked by the presence of established and emerging market players such as Arthrex Inc.; Smith & Nephew Plc.; DePuy Synthes (Johnson & Johnson MedTech); Stryker Corporation; CONMED Corporation; Zimmer Biomet Holdings Inc; KARL STORZ; IntraVu; Mueller Sports Medicine; and Orthofix International N.V. among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Organic and Inorganic Growth Strategies Adopted by Leading Players to Establish Their Foothold in the Sports Medicine Market
All key players operating in the sports medicine market are adopting both organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to garner a higher market share.
For instance,
• In November 2024, Johnson & Johnson MedTech signed an exclusive commercial distribution agreement with Responsive Arthroscopy Inc., which will strengthen its sports platform and meet the rising demand of the rapidly growing sports soft tissue repair market
• In August 2024, Zimmer Biomet Holdings, Inc. announced that it signed a definitive agreement to acquire OrthoGrid Systems, Inc. The acquisition will expand Zimmer Biomet's portfolio, which will now have OrthoGrid's AI-powered, fluoroscopy-based surgical assistance platform, Hip AI, as well as two additional FDA-cleared orthopedic applications and over 40 patents
• In July 2024, Stryker completed the acquisition of Artelon, specializing in innovative soft tissue fixation products for foot and ankle and sports medicine procedures
The sports medicine market is a growing market and is expected to gain further momentum in the upcoming years due to a strong emphasis on developing new minimally invasive products, investment in R&D to introduce several advanced products, increasing awareness regarding fitness regimes and sports activities, and aggressive organic and inorganic growth strategies followed by the market players.
Global Sports Medicine Market Segmentation
This report by Medi-Tech Insights provides the size of the global sports medicine market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, application, and end-user.
Download a sample report for in-depth competitive insights
https://meditechinsights.com/sports-medicine-market/request-sample/
Market Size & Forecast (2023-2030), By Product, USD Million
• Body Reconstruction
o Surgical Equipment
o Soft Tissue Repair
o Bone Reconstruction Devices
• Body Support & Recovery
o Braces and Other Support Devices
o Compression Clothing
o Hot & Cold Therapy
• Body Monitoring & Evaluation
• Accessories
o Bandages
o Tapes
o Disinfectants
o Wraps
o Other
Market Size & Forecast (2023-2030), By Application, USD Million
• Knee
• Shoulder
• Ankle & Foot
• Hip
• Spine Injuries
Market Size & Forecast (2023-2030), By End-user, USD Million
• Hospitals
• Ambulatory Surgical Centers
• Physiotherapy Clinics
• Others
Market Size & Forecast (2023-2030), By Region, USD Million
• North America
o US
o Canada
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o India
o Japan
o Rest of Asia Pacific
• Latin America
• Middle East & Africa
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
[email protected]
Top comments (0)